Novel action of gastric proton pump inhibitor on suppression of Helicobacter pylori induced angiogenesis. 2006

M Yeo, and D-K Kim, and S U Han, and J E Lee, and Y B Kim, and Y K Cho, and J H Kim, and S W Cho, and K-B Hahm
Genome Research Centre for Gastroenterology, Ajou University Medical Centre, San 5, Wonchon-dong, Yeongtong-gu, Suwon, 442-749, Korea. marie8346@hotmail.com

BACKGROUND Although activation of mitogen activated protein kinases (MAPKs) by Helicobacter pylori infection is associated with induction of host angiogenesis, which may contribute to H pylori associated gastric carcinogenesis, the strategy for its prevention has not been identified. As we previously reported a strong inhibitory action of gastric proton pump inhibitors (PPIs) on MAPK extracellular signal regulated kinase (ERK)1/2 phosphorylation, we investigated whether PPIs could suppress the H pylori induced angiogenesis via inhibition of MAPK ERK1/2. METHODS To address the relationship between H pylori infection and angiogenesis, comparative analysis of density of CD34(+) blood vessel was performed in tissues obtained from 20 H pylori positive gastritis and 18 H pylori negative gastritis patients. Expression of hypoxia inducible factor 1 (HIF-1alpha) and vascular endothelial growth factor (VEGF) was tested by reverse transcription-polymerase chain reaction and secretion of interleukin 8, and VEGF was measured by ELISA. To evaluate the direct effect of H pylori infection on the tubular formation of human umbilical vein endothelial cells (HUVEC), an in vitro angiogenesis assay was employed. Activation of MAPK and nuclear factor kappaB (NFkappaB) was detected by immunoblotting. RESULTS H pylori positive gastritis patients showed a higher density of CD34(+) blood vessels (mean 40.9 (SEM 4.4)) than H pylori negative gastritis patients (7.2+/-0.8), which was well correlated with expression of HIF-1alpha. Conditioned media from H pylori infected gastric epithelial cells directly induced tubular formation of HUVEC and the increase of in vitro angiogenesis was suppressed by PPI treatment. Infection of H pylori significantly upregulated expression of HIF-1alpha and VEGF in gastric epithelial cells and expression of proangiogenic factors was mediated by MAPK activation and partially responsible for NFkappaB activation. PPIs effectively inhibited the phosphorylation of MAPK ERK1/2 that is a principal signal for H pylori induced angiogenesis. CONCLUSIONS The fact that PPIs could downregulate H pylori induced angiogenesis indicates that antiangiogenic treatment using a PPI could be a promising protective therapeutic approach for H pylori associated carcinogenesis.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D005753 Gastric Mucosa Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones. Cardiac Glands,Gastric Glands,Pyloric Glands,Cardiac Gland,Gastric Gland,Gastric Mucosas,Gland, Cardiac,Gland, Gastric,Gland, Pyloric,Glands, Cardiac,Glands, Gastric,Glands, Pyloric,Mucosa, Gastric,Mucosas, Gastric,Pyloric Gland
D005756 Gastritis Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders. Gastritides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000897 Anti-Ulcer Agents Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. Anti-Ulcer Drugs,Agents, Anti-Ulcer,Anti Ulcer Agents,Anti Ulcer Drugs,Drugs, Anti-Ulcer
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings

Related Publications

M Yeo, and D-K Kim, and S U Han, and J E Lee, and Y B Kim, and Y K Cho, and J H Kim, and S W Cho, and K-B Hahm
August 1993, The American journal of gastroenterology,
M Yeo, and D-K Kim, and S U Han, and J E Lee, and Y B Kim, and Y K Cho, and J H Kim, and S W Cho, and K-B Hahm
February 1998, Archives of pharmacal research,
M Yeo, and D-K Kim, and S U Han, and J E Lee, and Y B Kim, and Y K Cho, and J H Kim, and S W Cho, and K-B Hahm
April 1993, Antimicrobial agents and chemotherapy,
M Yeo, and D-K Kim, and S U Han, and J E Lee, and Y B Kim, and Y K Cho, and J H Kim, and S W Cho, and K-B Hahm
January 1992, Scandinavian journal of gastroenterology,
M Yeo, and D-K Kim, and S U Han, and J E Lee, and Y B Kim, and Y K Cho, and J H Kim, and S W Cho, and K-B Hahm
January 1995, Journal of clinical gastroenterology,
M Yeo, and D-K Kim, and S U Han, and J E Lee, and Y B Kim, and Y K Cho, and J H Kim, and S W Cho, and K-B Hahm
April 2002, Alimentary pharmacology & therapeutics,
M Yeo, and D-K Kim, and S U Han, and J E Lee, and Y B Kim, and Y K Cho, and J H Kim, and S W Cho, and K-B Hahm
January 2012, World journal of gastroenterology,
M Yeo, and D-K Kim, and S U Han, and J E Lee, and Y B Kim, and Y K Cho, and J H Kim, and S W Cho, and K-B Hahm
October 1998, Annals of internal medicine,
M Yeo, and D-K Kim, and S U Han, and J E Lee, and Y B Kim, and Y K Cho, and J H Kim, and S W Cho, and K-B Hahm
February 1996, Biological & pharmaceutical bulletin,
M Yeo, and D-K Kim, and S U Han, and J E Lee, and Y B Kim, and Y K Cho, and J H Kim, and S W Cho, and K-B Hahm
June 2018, BMJ evidence-based medicine,
Copied contents to your clipboard!